Hypertension is associated with an increased risk of depression. Yet, combined rate of a depression diagnosis or use of an antidepressant was lower in patients prescribed angiotensin agents, calcium antagonists, and β-blockers, but not in patients prescribed diuretics.
Researchers conducted a prospective study to analyze the relationship between continued angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) use in the hospital and better clinical outcomes (ICU admission, morbidity, mortality).
Current angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use is associated with a slightly lower mortality risk in patients hospitalized with influenza or pneumonia.
Decompensation severity may be associated with increased risk for adverse clinical outcomes post-hospital discharge in patients with first-episode acute heart failure.
Researchers used data from the National Health and Nutrition Examination Survey 2009-2018 to assess the impact of drug and alcohol use on cardiometabolic disease risk factors.
For adults without hypertension, better cardiovascular health as measured by Life’s Simple 7 (LS7) is associated with a lower risk for incident hypertension.
